Navigation Links
Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Date:9/19/2011

ME-143. The second is a mitochondrial inhibitor program that includes lead candidate ME-344. The Company initiated a Phase I clinical trial of intravenous ME-143 in September 2011 and expects to submit an IND application for ME-344 by the first quarter of 2012. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; go
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives Positive Response From NASDAQ
5. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
6. Marshall Edwards Announces Private Placement
7. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
8. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
11. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015  Haemonetics Corporation (NYSE: ... Chief Operating Officer, will present at the JMP Securities ... on June 23 rd , 2015 at 11:30am ... Mr. Davies, presentation live via webcast at: http://wsw.com/webcast/jmp27/hae ... HAE ) is a global healthcare company dedicated ...
(Date:5/29/2015)... , May 29, 2015  World-renowned prostate surgeon and ... findings on the benefit of MR/Ultrasound Fusion-Guided Biopsy ... "Our Prostate Cancer Center at Lenox Hill Hospital ... Biopsy System in New York City . ... low risk prostate cancers. The use of an MRI makes ...
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical ... new drugs and tests, and this is ... instruments that can assist them. This according to ... Information said instruments such as mass spectrometry, ... in the identification of drug targets and ...
Breaking Medicine Technology:MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3
... 2011 /PRNewswire/ -- MEDX, Inc., a ... the next generation T-Quest™ compact gamma camera.  The ... features expanded imaging capabilities to perform parathyroid, sentinel ... other small organ studies.  The Company also announced ...
... 6, 2011 Life Extension, a global authority on ... supplements, has launched a product featuring ChromaDex,s (CDXC.OB) pTeroPure ... food stores and natural retailers. Life Extension ... naturally found in blueberries.  Pterostilbene has been shown ...
Cached Medicine Technology:MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras 2MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras 3Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 2Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 3
(Date:5/30/2015)... At 73 years old, Lynn Kendall is happily ... attributes to a lifetime of being health-conscious. She passes on ... of her new book titled “ Cook for Health and ... and Longevity” features a collection of recipes and ideas for ... It is designed to encourage a lifestyle of correct eating ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Cyclist ... tour, “Wheels for the World 2015: Piles of ... to raise awareness about hemophilia and encourage individuals ... Life. , Save One Life supports nearly ... eleven developing countries through direct sponsorships, scholarships and ...
(Date:5/30/2015)... San Luis Obispo insurance ... a free analysis and consultation for anyone interested in ... Awareness Month, which was created by the non-profit organization ... States such as Polk recognize the proclamation, and use ... possibility of disability, as well as the often-overlooked need ...
(Date:5/30/2015)... 30, 2015 The iconic American actor, ... be hosting a new segment on Medical Malpractice. This ... medical malpractice in the health care field. , According ... of medical malpractice suits were filed, roughly only 20% ... settled out of court, while the remaining 30% were ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 “ Milli the ... monthly AppWatch, which takes a look at the latest and ... Joe Toohey, the host of AppWatch and technology expert, conducted ... an aesthetic game that engages and educates children. , Interactive ... Unfortunately not all the content and games they are playing ...
Breaking Medicine News(10 mins):Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2
... preventing disease. In the future, skin ,cancer detection may be ... is a nine-year ,survivor of melanoma. He’s lucky doctors were ... found a primary, which is what you call the skin ... skin. It had already gotten into my lymph system,” he ...
... the first one to suspect health problems, including heart ... gum disease are at higher risk for heart attacks. ... heart disease, notes the Academy of General Dentistry. There's ... "I've helped patients with heart conditions by diagnosing dental ...
... another benefit of taking aspirin. A new study shows ... week may lower their risk of leukemia by more ... 28,000 women in the Iowa Women's Health Study to ... (NSAIDs), such as ibuprofen, could protect against leukemia. ,Results ...
... shows cholesterol-lowering effects from a pill formulated with ... first placebo-controlled clinical trial to confirm the cholesterol-lowering ... populations have suggested drinking tea has health benefits ... cholesterol. Studies confirming the causal relationship between tea ...
... benefit of vitamin D. ,Each year, 200,000 women in the ... shows one form of the vitamin may enhance the effect ... mice treated with radiation alone to mice exposed to both ... treatment, the tumor volume in those women treated //with EB ...
... their tedious marathons at the basin may do more harm ... people to brush too hard for too long, to the ... Hours of tests on brushing and scrubbing volunteers have found ... to gums,// particularly if the toothbrush user presses too hard. ...
Cached Medicine News:
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: